GT Biopharma, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $576.0K | $19.0K | $47.0K | $855.0K | $43.0K | $123.0K | $92.0K | $54.0K |
| Accounts Receivable | — | — | — | $0 | $40.0K | $0 | — | — |
| Inventory | — | — | — | $0 | $42.0K | $59.0K | $12.0K | — |
| Total Current Assets | $576.0K | $21.0K | $49.0K | $882.0K | $125.0K | $202.0K | $104.0K | $137.0K |
| Property, Plant & Equipment | $6.0K | $4.0K | $5.0K | $6.0K | $0 | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | $0 | $0 | $22.0K | $24.0K | $25.0K | $48.0K |
| Total Assets | $254.4M | $25.0K | $54.0K | $888.0K | $147.0K | $226.0K | $129.0K | $185.0K |
| Liabilities | ||||||||
| Accounts Payable | $2.5M | $2.1M | $893.0K | $412.0K | $940.0K | $878.0K | $806.0K | $625.0K |
| Total Current Liabilities | $2.7M | $18.9M | $49.9M | $29.8M | $6.4M | $6.6M | $5.2M | $5.7M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $2.7M | $18.9M | $50.6M | $30.5M | $6.5M | $6.6M | $5.2M | $5.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-269.5M | $-124.6M | $-134.4M | $-113.0M | $-89.5M | $-89.0M | $-83.8M | $-80.1M |
| Total Stockholders' Equity | $251.7M | $-18.9M | $-50.6M | $-29.6M | $-6.3M | $-6.3M | $-5.1M | $-5.5M |